SOX2 Mediates Metabolic Reprogramming of Prostate Cancer Cells

New strategies are needed to predict and overcome metastatic progression and therapy resistance in prostate cancer. One potential clinical target is the stem cell transcription factor SOX2, which has a critical role in prostate development and cancer. We thus investigated the impact of SOX2 expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wet, Larischa, Williams, Anthony, Gillard, Marc, Kregel, Steven, Lamperis, Sophia, Gutgesell, Lisa C., Vellky, Jordan E., Brown, Ryan, Conger, Kelly, Paner, Gladell P., Wang, Heng, Platz, Elizabeth E., De Marzo, Angelo M., Mu, Ping, Coloff, Jonathan L., Szmulewitz, Russell Z., Vander Griend, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858874/
https://www.ncbi.nlm.nih.gov/pubmed/35067686
http://dx.doi.org/10.1038/s41388-021-02157-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858874/
https://www.ncbi.nlm.nih.gov/pubmed/35067686
http://dx.doi.org/10.1038/s41388-021-02157-x

Ejemplares similares